| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biomarin Pharmaceutical Inc. (BMRN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. BMRN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 159.4K | $8.91M | - | |
| VP | 80.0K | $4.47M | - | |
| VP | 55.1K | $3.08M | - | |
| Dir | 49.4K | $2.76M | - | |
| Dir | 46.4K | $2.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2022 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 25,000 | $83.42 | $2,085,550.00 | -3.6% | +7.0% | +18.1% | |
| Apr 18, 2022 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 20,000 | $81.91 | $1,638,200.00 | -5.6% | +5.3% | +21.2% | |
| Apr 14, 2022 | Lawlis V Bryan53 | - | Sale+OE | 4,250 | $83.66 | $355,555.00 | -15.1% | +6.2% | +19.4% | |
| Apr 14, 2022 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 10,000 | $83.66 | $836,600.00 | -2.9% | +6.2% | +19.4% | |
| Apr 13, 2022 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 1,180 | $82.47 | $97,314.60 | -2.1% | +4.6% | +17.1% | |
| Mar 30, 2022 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 2,999 | $79.49 | $238,390.10 | -2.6% | +6.8% | +22.3% | |
| Mar 23, 2022 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 8,202 | $81.58 | $669,142.62 | -6.2% | -3.0% | +11.4% | |
| Mar 21, 2022 | Davis George Eric64 | EVP, General Counsel | Sell | 6,129 | $81.29 | $498,226.41 | -8.8% | -3.4% | +13.5% | |
| Mar 11, 2022 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 30,000 | $77.69 | $2,330,700.00 | -4.2% | +0.9% | +19.1% | |
| Feb 28, 2022 | Slamon Dennis | Director | Sell | 6,396 | $78.33 | $501,013.27 | -4.6% | -3.8% | +27.5% |